SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-001714
Filing Date
2024-01-08
Accepted
2024-01-08 07:00:12
Documents
12
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191269-8k_gamida.htm   iXBRL 8-K 35753
  Complete submission text file 0001213900-24-001714.txt   208609

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gmda-20240108.xsd EX-101.SCH 3024
3 XBRL LABEL FILE gmda-20240108_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE gmda-20240108_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT ea191269-8k_gamida_htm.xml XML 3415
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 24518257
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)